Pharmaceuticals & Biotechnology


Oraculum’s drug Regulatory intelligence (RI) team understands the importance of required Regulatory information, and how accurate should it be for a successful market entry. Starting from addressing any focused Regulatory query, an overview of the targeted country’s regulations, or assessing the Regulatory needs before product registration, Oraculum tailors its RI solution for drug categories to meet the diverse needs of global pharmaceutical and biopharmaceutical companies. To provide RI in a streamlined manner.

Oraculum has divided drug product categories as

  • New Chemical Entity/New Molecule Entity (NCE/NME)
  • Generic- Prescription
  • Generic- OTC
  • Biologics
  • Biosimilar
  • Vaccines
  • Orphan Drug
  • Traditional Medicine